Percutaneous injection of bone marrow mesenchymal stem cells for ankle non-unions decreases complications in patients with diabetes

[1]  E. Gómez-Barrena,et al.  Regulatory authorities and orthopaedic clinical trials on expanded mesenchymal stem cells , 2014, International Orthopaedics.

[2]  P. Rosset,et al.  Percutaneous grafting with bone marrow autologous concentrate for open tibia fractures: analysis of forty three cases and literature review , 2014, International Orthopaedics.

[3]  Y. Ebihara,et al.  Allogeneic stem cell transplantation for patients with acute myeloid leukaemia developing from severe congenital neutropenia , 2014, British journal of haematology.

[4]  A. Caplan,et al.  Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine , 2013, Experimental & Molecular Medicine.

[5]  Jiang Peng,et al.  Role of mesenchymal stem cells in bone regeneration and fracture repair: a review , 2013, International Orthopaedics.

[6]  T. Schepers,et al.  The timing of ankle fracture surgery and the effect on infectious complications; A case series and systematic review of the literature , 2013, International Orthopaedics.

[7]  M. Stojkovic,et al.  Regenerative Medicine Concise Review: Mesenchymal Stem Cell Treatment of the Complications of Diabetes Mellitus , 2022 .

[8]  Arthur S Slutsky,et al.  Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. , 2010, American journal of respiratory and critical care medicine.

[9]  M. Aschermann,et al.  Autologous intra-arterial infusion of bone marrow mononuclear cells in patients with critical leg ischemia. , 2008, International angiology : a journal of the International Union of Angiology.

[10]  J. Billiet,et al.  Autologous transplantation of bone marrow mononuclear cells for limb ischemia in a caucasian population with atherosclerosis obliterans , 2008, Journal of internal medicine.

[11]  Z. Han,et al.  Mesenchymal stem cells: biology and clinical potential in type 1 diabetes therapy , 2008, Journal of cellular and molecular medicine.

[12]  P. Wernet,et al.  Transplantation of autologous mononuclear bone marrow stem cells in patients with peripheral arterial disease (The TAM-PAD study) , 2007, Clinical Research in Cardiology.

[13]  D. Graves,et al.  Diminished Bone Formation During Diabetic Fracture Healing is Related to the Premature Resorption of Cartilage Associated With Increased Osteoclast Activity , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  W. Costigan,et al.  Operative Management of Ankle Fractures in Patients with Diabetes Mellitus , 2007, Foot & ankle international.

[15]  Frank A. Liporace,et al.  Diabetic fracture healing. , 2006, Foot and ankle clinics.

[16]  D. Wukich,et al.  Ankle fractures in diabetics. , 2006, Foot and ankle clinics.

[17]  P. Hernigou,et al.  Percutaneous autologous bone-marrow grafting for nonunions. Surgical technique. , 2006, The Journal of bone and joint surgery. American volume.

[18]  J. Nunley,et al.  The impact of diabetes on patient outcomes after ankle fracture. , 2005, The Journal of bone and joint surgery. American volume.

[19]  F Beaujean,et al.  Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. , 2005, The Journal of bone and joint surgery. American volume.

[20]  M. Pinzur,et al.  Ankle Arthrodesis with a Retrograde Femoral Nail for Charcot Ankle Arthropathy , 2005, Foot & ankle international.

[21]  I. Klöting,et al.  Influence of diabetic metabolic state on fracture healing in spontaneously diabetic rats , 2005, Diabetes/metabolism research and reviews.

[22]  C. Saltzman,et al.  Ankle fractures in patients with diabetes mellitus. , 2005, The Journal of bone and joint surgery. British volume.

[23]  Dan Ziegler,et al.  Diabetic neuropathies: a statement by the American Diabetes Association. , 2005, Diabetes care.

[24]  U. Boddenberg.  Heilungsdauer von Fuß- und Knöchelfrakturen bei Diabetikern: Literaturübersicht und Darstellung eigener Fälle , 2004 .

[25]  R. Hoyt,et al.  Peripheral arterial disease in people with diabetes: response to consensus statement. , 2004, Diabetes care.

[26]  H. Merk,et al.  Delayed remodeling in the early period of fracture healing in spontaneously diabetic BB/OK rats depending on the diabetic metabolic state. , 2004, Histology and histopathology.

[27]  J. Borrelli,et al.  A Protocol for Treatment of Unstable Ankle Fractures Using Transarticular Fixation in Patients with Diabetes Mellitus and Loss of Protective Sensibility , 2003, Foot & ankle international.

[28]  Andreas Lechner,et al.  Stem/progenitor cells derived from adult tissues: potential for the treatment of diabetes mellitus. , 2003, American journal of physiology. Endocrinology and metabolism.

[29]  J. Glowacki,et al.  Age‐related decline in the osteogenic potential of human bone marrow cells cultured in three‐dimensional collagen sponges , 2001, Journal of cellular biochemistry.

[30]  C. Boehm,et al.  Age‐ and gender‐related changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors , 2001, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[31]  P. Holstein,et al.  Long-term follow-up in diabetic Charcot feet with spontaneous onset. , 2000, Diabetes care.

[32]  J. Flynn,et al.  Closed Ankle Fractures in the Diabetic Patient , 2000, Foot & ankle international.

[33]  M. Chapman,et al.  Acute Complications in the Operative Treatment of Isolated Ankle Fractures in Patients with Diabetes Mellitus , 1999, Foot & ankle international.

[34]  E. Etchells,et al.  Clinical examination for the detection of protective sensation in the feet of diabetic patients , 1999, Journal of General Internal Medicine.

[35]  J. Johnson.  Instructional Course Lectures, The American Academy of Orthopaedic Surgeons - Operative Treatment of Neuropathic Arthropathy of the Foot and Ankle*† , 1998 .

[36]  J. Leith,et al.  Ankle fractures in diabetics. Complications of surgical management. , 1998, The Journal of bone and joint surgery. British volume.

[37]  W. F. Todd,et al.  The Natural History of Acute Charcot’s Arthropathy in a Diabetic Foot Specialty Clinic , 1997, Journal of the American Podiatric Medical Association.

[38]  L. Schon,et al.  The management of neuroarthropathic fracture-dislocations in the diabetic patient. , 1995, The Orthopedic clinics of North America.

[39]  G. Holmes,et al.  Fractures and Dislocations of the Foot and Ankle in Diabetics Associated with Charcot Joint Changes , 1994, Foot & ankle international.

[40]  R. Loder,et al.  The influence of diabetes mellitus on the healing of closed fractures. , 1988, Clinical orthopaedics and related research.

[41]  R. Cofield,et al.  Diabetic Neuroarthropathy in the Foot: Patient Characteristics and Patterns of Radiographic Change , 1983, Foot & ankle.

[42]  M. Hinsenkamp,et al.  Growth factors in orthopaedic surgery: demineralized bone matrix versus recombinant bone morphogenetic proteins , 2014, International Orthopaedics.

[43]  W. Taranow,et al.  Salvage of failed neuropathic ankle fractures: use of large-fragment fibular plating and multiple syndesmotic screws. , 2005, Journal of surgical orthopaedic advances.

[44]  U. Boddenberg.  [Healing time of foot and ankle fractures in patients with diabetes mellitus: literature review and report on own cases]. , 2004, Zentralblatt fur Chirurgie.

[45]  D. Graves,et al.  Diabetes interferes with the bone formation by affecting the expression of transcription factors that regulate osteoblast differentiation. , 2003, Endocrinology.

[46]  Peripheral Arterial Disease in People With Diabetes , 2003 .

[47]  A. Mokdad,et al.  Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. , 2003, JAMA.

[48]  J. Johnson.  Operative treatment of neuropathic arthropathy of the foot and ankle , 1998 .